- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03285789
Dyslexics' Visual Attention Field
Evaluation of the Visuo-attention Field of Symbols Versus Objects Visual Search in Dyslexic Subjects. DyslexiaSPOTLIGHT
dyslexia is often considered like a phonological deficit but some researches show that a visual attention (V-A) deficit can occur in dyslexia. The investigator want to show that some dyslexics have a reduced V-A field in visual search when the investigator use separable feature (letter-like).
If the investigator demonstrate that, he will show that V-A deficit can be transpose to an ability acquired before reading, the visual search. Therefore, the V-A deficit can't be a consequence of reading problem but a cause of it for some dyslexics.
The investigator could imagine an earlier diagnosis for children at risk to develop dyslexia and make reeducation more specific for the deficit observed.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bron, France, 69500
- U1028 INSERM - CNRS UMR 5292 Equipe ImpAct
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- normal or corrected to normal vision
- diagnosed dyslexics with a recent "alouette" test
Exclusion Criteria:
- other developmental problem (dysphasia, dyspraxia, ADHD)
- strabismus, amblyopia, oculomotor paralysis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: controls
|
Visual attention span : the subject see a 5 letters strings during 200 ms and he has to report it verbally whatever the order Visual search : the subject has to find a target among distractors (24 or 48) in different conditions of stimuli (conjunction feature or separable feature) and different conditions of view (full view or reduced view with the moving window paradigm) Elementary visuo spatial perception: the subject passes 6 visuo spatial test to judge his visuo spatial abilities. "test de l'alouette" : reading test during 3 minutes, we note the number of word read and the errors. We obtain lexical age. All of these tests will be made during an unique visit of 1h30. |
|
Experimental: Dyslexics with reduced visual attention span
21 subjects diagnosed dyslexics with reduced visual attention span
|
Visual attention span : the subject see a 5 letters strings during 200 ms and he has to report it orally whatever the order Visual search : the subject has to find a target among distractors (24 or 48) in different conditions of stimuli (conjunction feature or separable feature) and different conditions of view (full view or reduced view with the moving window paradigm) Elementary visuo spatial perception: the subject passes 6 visuo spatial tests to judge his visuo spatial abilities. All of these tests will be made during an unique visit of 1h30. |
|
Experimental: Dyslexics with normal visual attention span
|
Visual attention span : the subject see a 5 letters strings during 200 ms and he has to report it orally whatever the order Visual search : the subject has to find a target among distractors (24 or 48) in different conditions of stimuli (conjunction feature or separable feature) and different conditions of view (full view or reduced view with the moving window paradigm) Elementary visuo spatial perception: the subject passes 6 visuo spatial tests to judge his visuo spatial abilities. All of these tests will be made during an unique visit of 1h30. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respond time in visual search in different condition of view (full view or reduced view) with separable feature.
Time Frame: Day 0
|
The subject will have to find a target among distractors, when he will find it, he will have to push a button and we will have his respond time.
We will compare the respond time in two view condition: the participant will see all the visual scene or he will have reduced visible window so he won't see all the scene, the periphery will be hide and he will have to move his sight to show it.
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
respond time in function of the distractors' number
Time Frame: Day 0
|
The subject will have to find a target among distractors, when he will find it, he will have to push a button and we will collect his respond time.
We compare the respond time between two number of distractors (24 or 48)
|
Day 0
|
|
visual exploration of the scene
Time Frame: Day 0
|
with an eye tracker the investigator will analyze the ocular movements during visual search (saccades and fixations) and the equip will compare the visual behavior between the different groups and the different conditions.
|
Day 0
|
|
visuo-spatial perception
Time Frame: Day 0
|
the investigator will test with different exercises the elementary visuo spatial perception of the participant and he will compare between groups and also he will make correlation with the respond time in visual search.
|
Day 0
|
|
visual attention span (VAS)
Time Frame: Day 0
|
the subject have to report orally a 5 letters' string presented during 200 ms, the investigator could see if a correlation exist between VAS and RT, VAS and visual exploration, VAS and visuo spatial perception.
|
Day 0
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laure PISELLA, PhD, INSERM U1028 - Impact - CRNL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL17_0333
- 2017-A02525-48 (Other Identifier: ID-RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyslexia
-
Catholic University of the Sacred HeartFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione I.R...Enrolling by invitationDevelopmental DyslexiaItaly
-
University of ZurichUnknown
-
Silvia BremSwiss National Science FoundationRecruitingDyslexia | Learning Disabilities | Learning | Dyslexia, Developmental | ReadingSwitzerland
-
Bambino Gesù Hospital and Research InstituteRecruitingDevelopmental DyslexiaItaly
-
Bambino Gesù Hospital and Research InstituteEnrolling by invitationDevelopmental DyslexiaItaly
-
Scalab CNRS 9193UnknownDevelopmental DyslexiaFrance
-
Catholic University of the Sacred HeartUnknown
-
University Hospital, ToursCompleted
-
IRCCS Eugenio MedeaFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; University of MilanRecruiting
-
Georgia State UniversityMedical University of South Carolina; National Institutes of Health (NIH)CompletedDevelopmental Reading Disorder | Dyslexia, DevelopmentalUnited States
Clinical Trials on Passing tests in dyslexics with reduced eva
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingOld Age | TBI | HSCT | Aplastic Anaemia
-
Universidad de GranadaUniversity of Copenhagen; University of Oxford; Harvard University; University... and other collaboratorsCompleted
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingAthletic Performance | Heart Rate VariabilityTurkey
-
Comenius UniversitySanatórium of Dr. Guhr, n.o.; Kaneka Pharma Europe N.V.CompletedCOVID-19 Respiratory InfectionSlovakia
-
Abbott Medical DevicesCompletedAtrial Fibrillation, Persistent | Cardiac Arrhythmia | Ablation | Atrial Fibrillation ParoxysmalUnited States
-
Hospices Civils de LyonRecruitingRespiratory Viral InfectionFrance
-
University of Alabama at BirminghamBracco CorporateCompletedBreast Malignant Tumor | Breast Benign TumorUnited States
-
Italian Society of CardiologyFederico II University; University Of Perugia; University of Messina; Azienda Ospedaliero-Universitaria... and other collaboratorsCompletedLeft Ventricular Dysfunction | Ventricular Remodeling | Heart Failure, Left SidedItaly
-
PETHEMA FoundationCompletedAcute Lymphoblastic LeukemiaSpain
-
University Hospital, GrenobleEtablissement Français du SangNot yet recruitingEndometriosis | Immunity | MicrobiotaFrance